Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B - Containing lipoproteins: Evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies

Diabetes

Volumn 53, Issue 12, 2004, Pages 3057-3066

  Qiu, Wei ^a   Avramoglu, Rita Kohen ^a   Dubé, Nadia ^b   Chong, Taryne M ^a   Naples, Mark ^a   Au, Crystal ^a   Sidiropoulos, Konstantinos G ^a   Lewis, Gary F ^c   Cohn, Jeffrey S ^d   Tremblay, Michel L ^b   Adeli, Khosrow ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN B; FRUCTOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LIPOPROTEIN; PROTEIN TYROSINE PHOSPHATASE 1B; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DIET; DYSLIPIDEMIA; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SUGAR INTAKE; WEIGHT GAIN;

ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CELL LINE; CELL LINE, TUMOR; CHOLESTEROL; HEPATOCYTES; HUMANS; LIVER; MICE; MICE, KNOCKOUT; PROTEIN-TYROSINE-PHOSPHATASE; REFERENCE VALUES; RNA, ANTISENSE; RNA, SMALL INTERFERING; TRANSFECTION; TRIGLYCERIDES;

EID: 9444258581     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.12.3057     Document Type: Article

References (58)

1. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG: The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68:545-560, 1992
2. Haj FG, Verveer PJ, Squire A, Neel BG, Bastiaens PI: Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295:1708-1711, 2002
3. Cheng A, Dube N, Gu F, Tremblay ML: Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem 269:1050-1059, 2002
4. Hashimoto N, Zhang WR, Goldstein BJ: Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system. Biochem J 284:569-576, 1992
5. Kennedy BP, Ramachandran C: Protein tyrosine phosphatase-1B in diabetes. Biochem Pharmacol 60:877-883, 2000
6. Lammers R, Bossenmaier B, Cool DE, Tonks NK, Schlessinger J, Fischer EH, Ullrich A: Differential activities of protein tyrosine phosphatases in intact cells. J Biol Chem 268:22456-22462, 1993
7. Tonks NK, Diltz CD, Fischer EH: Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263:6722-6730, 1988
8. Ahmad F, Goldstein BJ: Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. Am J Physiol 268:E932-E940, 1995
9. Ahmad F, Goldstein BJ: Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44:1175-1184, 1995
10. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Coffins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-1548, 1999
11. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB: Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479-5489, 2000
12. Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA, Trevillyan JM, Ulrich RG, Jirousek MR, Rondinone CM: Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52:21-28, 2003
13. Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE, Reilly RM, Koterski S, Opgenorth TJ, Ulrich RG, Crosby S, Butler M, Murray SF, McKay RA, Bhahot S, Monia BP, Jirousek MR: PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA 99:11357-11362, 2002
14. Clampit JE, Meuth JL, Smith HT, Reilly RM, Jirousek MR, Trevillyan JM, Rondinone CM: Reduction of protein-tyrosine phosphatase-1B increases insulin signaling in FAO hepatoma cells. Biochem Biophys Res Commun 300:261-267, 2003
15. Echwald SM, Bach H, Vestergaard H, Richelsen B, Kristensen K, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O: A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 51:1-6, 2002
16. Mok A, Caci H, Zinman B, Hanley AJ, Harris SB, Kennedy BP, Hegele RA: A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree. J Clin Endocrinol Metab 87:724-727, 2002
17. Gu F, Dube N, Kim JW, Cheng A, Ibarra-Sanchez MJ, Tremblay ML, Boisclair YR: Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling. Mol Cell Biol 23:3753-3762, 2003
18. Kaszubska W, Falls HD, Schaefer VG, Haasch D, Frost L, Hessler P, Kroeger PE, White DW, Jirousek MR, Trevillyan JM: Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line. Mol Cell Endocrinol 195:109-118, 2002
19. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG: PTP1B regulates leptin signal transduction in vivo. Dev Cell 2:489-495, 2002
20. Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, Le Tien H, Fantus IG, Lewis GF, Adeli K: Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 277:793-803, 2002
21. Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P: Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37:982-987, 1988
22. Garg A: Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 19:387-389, 1996
23. Moller DE, Flier JS: Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 325:938-948, 1991
24. Mykkanen L, Haffner SM, Ronnemaa T, Bergman R, Leino A, Laakso M: Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? Metabolism 43:523-528, 1994
25. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
26. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
27. Hauner H: Insulin resistance and the metabolic syndrome: a challenge of the new millennium. Eur J Clin Nutr 56 (Suppl 1):S25-S29, 2002
28. Siri P, Candela N, Zhang YL, Ko C, Eusufzai S, Ginsberg HN, Huang LS: Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance. J Biol Chem 276:46064-46072, 2001
29. Taghibiglou C, Rudy D, Van Iderstine SC, Aiton A, Cavallo D, Cheung R, Adeli K: Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes. J Lipid Res 41:499-513, 2000
30. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K: Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance: evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275:8416-8425, 2000
31. Arbeeny CM, Meyers DS, Bergquist KE, Gregg RE: Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J Lipid Res 33:843-851, 1992
32. Hoang VQ, Botham KM, Benson GM, Eldredge EE, Jackson B, Pearce N, Suckling KE: Bile acid synthesis in hamster hepatocytes in primary culture: sources of cholesterol and comparison with other species. Biochim Biophys Acta 1210:73-80, 1993
33. Jackson B, Gee AN, Martinez-Cayuela M, Suckling KE: The effects of feeding a saturated fat-rich diet on enzymes of cholesterol metabolism in the liver, intestine and aorta of the hamster. Biochim Biophys Acta 1045:21-28, 1990
34. Liu GL, Fan LM, Redinger RN: The association of hepatic apoprotein and lipid metabolism in hamsters and rats. Comp Biochem Physiol A 99:223-228, 1991
35. Nistor A, Bulla A, Filip DA, Radu A: The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68:159-173, 1987
36. Sullivan MP, Cerda JJ, Robbins FL, Burgin CW, Beatty RJ: The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab Anim Sci 43:575-578, 1993
37. Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, Buckingham R, Adeli K, Lewis GF: Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277: 28795-28802, 2002
38. Brown AM, Gibbons, GF: Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event. Arterioscler Thromb Vasc Biol 21:1656-1661, 2001
39. Sparks JD, Phung TL, Bolognino M, Sparks CE: Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem J 313: 567-574, 1996
40. Dall'Aglio E, Tosini P, Zavaroni I, Olivetti G, Reaven GM: Comparison of the metabolic changes in rats with hypertension secondary to fructose feeding or renal artery stenosis. Am J Hypertens 8:524-527, 1995
41. Kasim-Karakas SE, Vriend H, Almario R, Chow LC, Goodman MN: Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. J Lab ClinMed 128:208-213, 1996
42. Yoshino G, Matsushita M, Iwai M, Monta M, Matsuba K, Nagata K, Maeda E, Furukawa S, Hirano T, Kazumi T: Effect of mild diabetes and dietary fructose on very-low-density lipoprotein triglyceride turnover in rats. Metabolism 41:236-240, 1992
43. Lewis GF, Carpentier A, Adeli K, Giacca A: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229, 2002
44. Shah P, Basu A, Rizza R: Fat-induced liver insulin resistance. Curr Diab Rep 3:214-218, 2003
45. Sparks JD, Sparks CE: Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta 1215:9-32, 1994
46. Sparks CE, Sparks JD, Bolognino M, Salhanick A, Strumph PS, Amatruda JM: Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism 35:1128-1136, 1986
47. Sparks JD, Sparks CE: Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem 265:8854-8862, 1990
48. Avramoglu RK, Qiu W, Adeli K: Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion. Front Biosci 8:d464-d476, 2003
49. Kuriyama H, Yamashita S, Shimomura I, Funahashi T, Ishigami M, Aragane K, Miyaoka K, Nakamura T, Takemura K, Man Z, Toide K, Nakayama N, Fukuda Y, Lin MC, Wetterau JR, Matsuzawa Y: Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology 27:557-562, 1998
50. Shimizu S, Ugi S, Maegawa H, Egawa K, Nishio Y, Yoshizaki T, Shi K, Nagai Y, Morino K, Nemoto K, Nakamura T, Bryer-Ash M, Kashiwagi A: Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem 278: 43095-43101, 2003
51. Phung TL, Roncone A, Jensen KL, Sparks CE, Sparks JD: Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem 272:30693-30702, 1997
52. Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A: Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in 16 myocytes and Fao hepatoma cells. J Biol Chem 276:10207-10211, 2001
53. Venable CL, Frevert EU, Kim YB, Fischer BM, Kamatkar S, Neel BG, Kahn BB: Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation. J Biol Chem 275:18318-18326, 2000
54. Borradaile NM, de Dreu LE, Huff MW: Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 52:2554-2561, 2003
55. Au CS, Wagner A, Chong T, Qiu W, Sparks JD, Adeli K: Insulin regulates hepatic apolipoprotein B production independent of the mass or activity of Akt1/PKBα. Metabolism 53:228-235, 2004
56. Adeli K, Macri J, Mohammadi A, Kito M, Urade R, Cavallo D: Apolipoprotein B is intracellularly associated with an ER-60 protease homologue in HepG2 cells. J Biol Chem 272:22489-22494, 1997
57. Qiu W, Kohen-Avramoglu R, Rashid-Kolvear F, Au CS, Chong TM, Lewis GF, Trinh DK, Austin RC, Urade R, Adeli K: Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway. Biochemistry 43:4819-4831, 2004
58. Jackson TK, Salhanick AI, Elovson J, Deichman ML, Amatruda JM: Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes. J Clin Invest 86:1746-1751, 1990